Recombinant DNA News and Research

RSS
Recombinant DNA is a variety of techniques that molecular biologists use to manipulate DNA molecules to study the expression of a gene.
Neurologix reports new results from NLX-P101 Phase 2 trial against Parkinson's disease

Neurologix reports new results from NLX-P101 Phase 2 trial against Parkinson's disease

Adaptimmune announces opening of Phase I/II clinical trial in multiple myeloma

Adaptimmune announces opening of Phase I/II clinical trial in multiple myeloma

GeoVax Labs expands its HIV/AIDS vaccine program with NIAID, NIH and HVTN

GeoVax Labs expands its HIV/AIDS vaccine program with NIAID, NIH and HVTN

GeoVax Labs to update its HIV/AIDS vaccine status at World Vaccine Conference

GeoVax Labs to update its HIV/AIDS vaccine status at World Vaccine Conference

Merck's VICTRELIS phase III study results against HCV presented at EASL annual meeting

Merck's VICTRELIS phase III study results against HCV presented at EASL annual meeting

City Of Hope opens new center for diabetes research and care

City Of Hope opens new center for diabetes research and care

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

IRBNet releases National Research Network 2010 Benchmark Report

IRBNet releases National Research Network 2010 Benchmark Report

GeoVax's phase 2a trial results indicate excellent safety profile for HIV vaccine

GeoVax's phase 2a trial results indicate excellent safety profile for HIV vaccine

GeoVax expands Phase 2a clinical trial for MVA62B HIV/AIDS vaccine

GeoVax expands Phase 2a clinical trial for MVA62B HIV/AIDS vaccine

Cyplasin selects Aurobindo Pharma to supply API component for Ribavirin drug

Cyplasin selects Aurobindo Pharma to supply API component for Ribavirin drug

Science and precedent do not support biosimilar approach for plasma protein therapies

Science and precedent do not support biosimilar approach for plasma protein therapies

UCSF professor receives National Medal of Science

UCSF professor receives National Medal of Science

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

Conference to discuss frontline of immunological research, its clinical application

Conference to discuss frontline of immunological research, its clinical application

Medicago included in President's report that examines drugs to prevent spread of infectious diseases

Medicago included in President's report that examines drugs to prevent spread of infectious diseases

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

Merck signs non-exclusive license agreement with LabCorp for commercialization of genetic test

Merck signs non-exclusive license agreement with LabCorp for commercialization of genetic test

New research identifies stem cells that generate three critical classes of nerve cells

New research identifies stem cells that generate three critical classes of nerve cells

Tepha receives $3.2 million credit facility from GE Capital

Tepha receives $3.2 million credit facility from GE Capital